Clinical Trial Update: A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia [Phase 1]

View source ↗

Summary

The Phase 1 trial of nomlabofusp in adolescents and children with Friedreich's Ataxia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Nomlabofusp

Snippet

Sponsor: Larimar Therapeutics, Inc. | Conditions: Friedreich Ataxia | Phase 1 | Status: TERMINATED